The new Image-to-video feature for Veo 3 is sure to further expand the video pool online
To no one’s surprise, Grok 4 checks with Elon’s opinions
Multiple reddit and X.com users report how the new «maximally truth-seeking» Grok model checks with Elon Musk’s X account and interviews to align with his views in its reasoning. This comes hot on the heels of Grok 3 shutting down for spewing nazi conspiracies, after Elon accused it of being too aligned with left wing media.
More at TechCrunch, and CNBC who both confirm the reports.
Image-to-video generation comes to Veo 3
After opening up Veo 3 worldwide for Gemini Pro users and teasing the feature last week, it’s finally gone live globally.
It is now possible to upload a picture and have it animated in an 8-second 720p video if you are a Gemini Pro ($20/month) or Ultra ($250/month) user.
Simply upload a photo, add any instructions for the scene you want to create, and two minutes later you should have a nicely animated video. Google also says they have generated over 40 million videos since Veo 3’s inception in May.
More at Google’s blog and on 9to5Google.
In coming update, Youtube will demonetize «inauthentic» content
In a battle against «AI slop,» as in mass produced, unoriginal content chruned out at scale and made by AI tools, Youtube is now saying they will clarify their position on «inauthentic» content on July 15. They already have an extensive page on AI tools, but requires their use to be «original» and «authentic» and is seeing a lot of misuse. These videos will likely be demonetized shortly.
More at Youtube’s policy updates, and Gizmodo bemoans AI slop, as usual.
Alphabet’s Isomorphic Labs promises a cure for every disease
Isomorphic Labs president Colin Murdoch has spoken to Fortune about his ambitions to use AI discovery to find cures for just about anything. They are a spinoff from the AlphaFold unit and are «collaborating with AI to design drugs for cancer,» «right now,» he says.
The next stage is doing human trials on some of the drugs they have discovered, which can be a long and cumbersome process, but is crucial to getting the drugs approved.
«We’re staffing up now. We’re getting very close,» says Murdoch, and «we’re making good progress.»
Read the full interview at Fortune.
